1
|
Bannour B, Baazaoui M, Bannour M, Bannour I, Abdellaoui H, Ben Jazia K. Seizures in the third trimester of pregnancy- A rare case of Wernicke's encephalopathy mimicking Eclampsia. Radiol Case Rep 2024; 19:2039-2042. [PMID: 38449490 PMCID: PMC10917636 DOI: 10.1016/j.radcr.2024.02.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2023] [Revised: 02/07/2024] [Accepted: 02/09/2024] [Indexed: 03/08/2024] Open
Abstract
Unless otherwise demonstrated, seizures during pregnancy that happen after 20 weeks of gestation are typically caused by eclampsia. In our clinical case we report the diagnostic challenge of Wernicke's encephalopathy occurring at 34 weeks and mimicking an eclamptic attack. This is about a 30-year-old female patient who suffers from hyperemesis gravidarum during her pregnancy. she has no known history of epilepsy .The patient was brought to the emergency room by medical transport at 34 weeks of gestation due to a seizure at home. The initial diagnosis was eclampsia. Emergency high-level extraction under general anesthesia was decided for maternal rescue. However, after extubation, the patient's condition deteriorated, with the onset of a confusion syndrome characterized by agitation, temporal-spatial disorientation, attention and vigilance disorders, and challenging communication. Angio MRI was performed, revealing signs consistent with Wernicke's encephalitis.
Collapse
Affiliation(s)
- Badra Bannour
- Department of obstetrics and gynecology, university hospital Farhat Hached of Sousse
- University of Sousse, faculty of medicine of Sousse, Tunisia
| | - Maroi Baazaoui
- Department of obstetrics and gynecology, university hospital Farhat Hached of Sousse
- University of Sousse, faculty of medicine of Sousse, Tunisia
| | - Maroi Bannour
- Department of Anesthesiology-Intensive Care, University Hospital Farhat Hached, Sousse, Tunisia
- University of Sousse, faculty of medicine of Sousse, Tunisia
| | - Imen Bannour
- Department of obstetrics and gynecology, university hospital Farhat Hached of Sousse
- University of Sousse, faculty of medicine of Sousse, Tunisia
| | - Hiba Abdellaoui
- Department of obstetrics and gynecology, university hospital Farhat Hached of Sousse
- University of Sousse, faculty of medicine of Sousse, Tunisia
| | - Khaled Ben Jazia
- Department of Anesthesiology-Intensive Care, University Hospital Farhat Hached, Sousse, Tunisia
- University of Sousse, faculty of medicine of Sousse, Tunisia
| |
Collapse
|
2
|
Mori H, Kondo E, Yoshino K. Acute Myositis in a Pregnant Woman Complicated With COVID-19 and Hyperemesis Gravidarum: A Case Report. J UOEH 2023; 45:161-165. [PMID: 37661388 DOI: 10.7888/juoeh.45.161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/05/2023]
Abstract
Myalgia is the most frequently reported neuromuscular symptom in COVID-19 patients, with a frequency of around 20% in pregnant women. Acute myositis due to COVID-19 is severe and requires medical intervention. There have been some reports of acute myositis due to COVID-19, mostly in elderly men, but rarely in pregnant women. Here we report a case of a pregnant woman who was diagnosed with acute myositis following COVID-19 illness early in her pregnancy. She had been affected by morning sickness since the 6th week of gestation and was diagnosed with COVID-19 at the 12th week. Muscle pain appeared in her limbs 5 days after the diagnosis of COVID-19, with a predominance of pain in the lower limbs, and her gait gradually became unstable. We concluded that it was acute myositis complicated by COVID-19 and hypokalemia, but we could not determine whether hypokalemia or COVID-19 or both were the cause of the muscle damage in this case. Pregnant women diagnosed with COVID-19 often complain of myalgia and fatigue, and when a pregnant woman's symptoms are severe we should keep in mind that they may be suffering from muscle damage that needs medical intervention.
Collapse
Affiliation(s)
- Hiroshi Mori
- Department of Obstetrics and Gynecology, School of Medicine, University of Occupational and Environmental health, Japan
| | - Emi Kondo
- Department of Obstetrics and Gynecology, School of Medicine, University of Occupational and Environmental health, Japan
| | - Kiyoshi Yoshino
- Department of Obstetrics and Gynecology, School of Medicine, University of Occupational and Environmental health, Japan
| |
Collapse
|
3
|
Araujo-Chaveron L, Doncarli A, Vivanti AJ, Salanave B, Lasbeur L, Gorza M, Raude J, Regnault N. Perception of the SARS-CoV-2 pandemic by pregnant women during the first lockdown in France: worry, perceived vulnerability, adoption and maintenance of prevention measures according to the Covimater study. Prev Med Rep 2022; 27:101807. [PMID: 35495869 PMCID: PMC9040418 DOI: 10.1016/j.pmedr.2022.101807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2021] [Revised: 04/22/2022] [Accepted: 04/24/2022] [Indexed: 11/17/2022] Open
Abstract
Participants’ main worries concerned risks for their pregnancy or relatives. Perceived vulnerability linked to obesity and lack of professional health advice. Knowledge of viral transmission favoured implementation of prevention measures.
Background We aimed to describe pregnant women’s worry about the SARS-CoV-2 pandemic, the associated reasons, their perceived vulnerability to this infection, and factors influencing continued poor/non-existent or decreased implementation of preventive measures over time. Method A cross-sectional study was conducted in July 2020 using a web-questionnaire completed by 500 women who were pregnant during the first lockdown in France (March–May 2020). Questions focused on worry caused by the pandemic, perceived vulnerability to infection by SARS-CoV-2 and implementation of preventive measures during and after lockdown. A robust variance Poisson regression model was used to estimate adjusted prevalence ratios (aPR) for perceived vulnerability and continued poor/non-existent or decreased implementation of preventive measures. Results Participants felt significantly more vulnerable to infection than women of childbearing age who were included in a parallel study on the French general population, but were significantly less worried about the pandemic. Obese participants and those who unsuccessfully sought exchanges with healthcare professionals about their infection risk felt significantly more vulnerable (aPR = 1.32 95%CI[1.05–1.64] and 1.88 [1.43–2.48], respectively). Participants with continued poor/non-existent or decreased implementation of preventive measures two months after the lockdown ended were more likely to have experienced violence during the lockdown (2.06, [1.32–3.22]), or to live in areas less affected by the pandemic (1.66 [1.05–2.62]). A good knowledge of viral transmission (0.54 [0.30–0.97]) and a high perceived vulnerability score (0.66 [0.44–0.99]) were associated with maintained/increased implementation of preventive measures. Conclusions Our results can guide prevention and support policies for pregnant women during pandemics, current or future.
Collapse
Affiliation(s)
- Lucia Araujo-Chaveron
- Direction of Non-Communicable Diseases and Trauma, Santé Publique France, Saint-Maurice, France
| | - Alexandra Doncarli
- Direction of Non-Communicable Diseases and Trauma, Santé Publique France, Saint-Maurice, France
| | - Alexandre J Vivanti
- Division of Obstetrics and Gynecology, Antoine Béclère Hospital, Clamart, France.,Paris Saclay University Hospital, Clamart, France
| | - Benoît Salanave
- Direction of Non-Communicable Diseases and Trauma, Santé Publique France, Saint-Maurice, France
| | - Linda Lasbeur
- Direction of Prevention and Promotion of health, Santé Publique France, Saint-Maurice, France
| | - Maud Gorza
- Direction of Prevention and Promotion of health, Santé Publique France, Saint-Maurice, France
| | - Jocelyn Raude
- Ecole des Hautes Etudes en Santé Publique (EHESP), Rennes, France
| | - Nolwenn Regnault
- Direction of Non-Communicable Diseases and Trauma, Santé Publique France, Saint-Maurice, France
| |
Collapse
|
4
|
Doncarli A, Araujo-Chaveron L, Crenn-Hebert C, Demiguel V, Boudet-Berquier J, Barry Y, Gomes Do Espirito Santo ME, Guajardo-Villar A, Menguy C, Tabaï A, Wyndels K, Benachi A, Regnault N. Impact of the SARS-CoV-2 pandemic and first lockdown on pregnancy monitoring in France: the COVIMATER cross-sectional study. BMC Pregnancy Childbirth 2021; 21:799. [PMID: 34847872 PMCID: PMC8630988 DOI: 10.1186/s12884-021-04256-9] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2021] [Accepted: 11/09/2021] [Indexed: 12/27/2022] Open
Abstract
BACKGROUND In the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, consultations and pregnancy monitoring examinations had to be reorganised urgently. In addition, women themselves may have postponed or cancelled their medical monitoring for organisational reasons, for fear of contracting the disease caused by SARS-CoV-2 (COVID-19) or for other reasons of their own. Delayed care can have deleterious consequences for both the mother and the child. Our objective was therefore to study the impact of the SARS-CoV-2 pandemic and the first lockdown in France on voluntary changes by pregnant women in the medical monitoring of their pregnancy and the associated factors. METHODS A cross-sectional study was conducted in July 2020 using a web-questionnaire completed by 500 adult (> 18 years old) pregnant women during the first French lockdown (March-May 2020). A robust variance Poisson regression model was used to estimate adjusted prevalence ratios (aPRs). RESULTS Almost one women of five (23.4%) reported having voluntarily postponed or foregone at least one consultation or pregnancy check-up during the lockdown. Women who were professionally inactive (aPR = 1.98, CI95%[1.24-3.16]), who had experienced serious disputes or violence during the lockdown (1.47, [1.00-2.16]), who felt they received little or no support (1.71, [1.07-2.71]), and those who changed health professionals during the lockdown (1.57, [1.04-2.36]) were all more likely to have voluntarily changed their pregnancy monitoring. Higher level of worry about the pandemic was associated with a lower probability of voluntarily changing pregnancy monitoring (0.66, [0.46-0.96]). CONCLUSIONS Our results can guide prevention and support policies for pregnant women in the current and future pandemics.
Collapse
Affiliation(s)
- Alexandra Doncarli
- Santé publique France, French national public health agency, Non-Communicable Diseases and Trauma Division, Perinatology, Early childhood and Mental Health Unit, 14, rue du Val d'Osne, F-94415, Saint-Maurice, France.
| | - Lucia Araujo-Chaveron
- Santé publique France, French national public health agency, Non-Communicable Diseases and Trauma Division, Perinatology, Early childhood and Mental Health Unit, 14, rue du Val d'Osne, F-94415, Saint-Maurice, France
| | - Catherine Crenn-Hebert
- Department of Gynecology and Obstetrics, Louis Mourier University Hospital, AP-HP, Colombes, France
| | - Virginie Demiguel
- Santé publique France, French national public health agency, Non-Communicable Diseases and Trauma Division, Perinatology, Early childhood and Mental Health Unit, 14, rue du Val d'Osne, F-94415, Saint-Maurice, France
| | - Julie Boudet-Berquier
- Santé publique France, French national public health agency, Non-Communicable Diseases and Trauma Division, Perinatology, Early childhood and Mental Health Unit, 14, rue du Val d'Osne, F-94415, Saint-Maurice, France
| | - Yaya Barry
- Santé publique France, French national public health agency, Non-Communicable Diseases and Trauma Division, Perinatology, Early childhood and Mental Health Unit, 14, rue du Val d'Osne, F-94415, Saint-Maurice, France
| | - Maria-Eugênia Gomes Do Espirito Santo
- Santé publique France, French national public health agency, Non-Communicable Diseases and Trauma Division, Perinatology, Early childhood and Mental Health Unit, 14, rue du Val d'Osne, F-94415, Saint-Maurice, France
| | - Andrea Guajardo-Villar
- Santé publique France, French national public health agency, Data processing, support and analysis department, Saint-Maurice, France
| | - Claudie Menguy
- Santé publique France, French national public health agency, Non-Communicable Diseases and Trauma Division, Perinatology, Early childhood and Mental Health Unit, 14, rue du Val d'Osne, F-94415, Saint-Maurice, France
| | - Anouk Tabaï
- Santé publique France, French national public health agency, Alert and crisis department, Saint-Maurice, France
| | - Karine Wyndels
- Santé Publique France, French national public health agency, Hauts-de-France regional office, Saint-Maurice, France
| | - Alexandra Benachi
- Division of Obstetrics and Gynecology, Antoine Béclère Hospital, AP-HP, Clamart, France
- Paris Saclay University, Clamart, France
| | - Nolwenn Regnault
- Santé publique France, French national public health agency, Non-Communicable Diseases and Trauma Division, Perinatology, Early childhood and Mental Health Unit, 14, rue du Val d'Osne, F-94415, Saint-Maurice, France
| |
Collapse
|
5
|
Gandhi AM, Ganatra AM, Tank P. Preliminary Results from the FOGSI's National Registry on Pregnancy with COVID-19. J Obstet Gynaecol India 2021; 71:361-368. [PMID: 34483513 PMCID: PMC8405343 DOI: 10.1007/s13224-021-01537-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2021] [Accepted: 08/02/2021] [Indexed: 12/18/2022] Open
Abstract
Background/purpose of the study The obstetric population is believed to be more susceptible to adverse consequences of coronavirus disease COVID-19 as compared to the general populace. Clinical characteristics and outcomes data related to COVID-19 infection in obstetric cases are limited and evolving. Most importantly, studies reporting Indian data are strikingly few and of single centre. The objective of our study was thus to address these lacunae using data registered in the FOGSI’s National registry on COVID-19 infection in pregnancy (FOGSI COVID registry). Methods We conducted an observational study using data retrieved from the FOGSI COVID registry. Fifty-three hospital departments participating in the registry populated data related to laboratory confirmed and hospitalized COVID-19 obstetric patients. Data for the period of 28 April 2020 to 28 August 2020 were extracted from the registry. A subset of the data was formatted, curated, standardized and harmonized. Descriptive analysis was carried out, and results reported. Results Of the 989 cases analyzed, 956 women were pregnant and 33 women were in the postpartum period. A total of 569 women (61.71%, n = 922) were multi-gravida, and 713 women (72.98%, n = 977) belonged to the 21–30 years age group. A total of 492 cases (52.73%, n = 966) had a gestational age > 37 weeks. A total of 754 women (83.41%, n = 904) were asymptomatic, and 32 cases (3.54%, n = 904) had severe acute respiratory infection (SARI). Fifty-six women (7.19%, n = 779) required critical care and ten women (1.01%, n = 989) died. A total of 771 pregnant women (97.23%, n = 793) gave birth of which 455 cases (59.01%) underwent a lower segment caesarean section (LSCS). There were 749 cases (95.17%, n = 771) of live birth that included eight cases of twin deliveries. 195 infants (28.34%, n = 688) were admitted to the NICU, and 13 infants (2.99%, n = 435) tested COVID-19 positive in the neonatal period. Twelve infants (1.54%, n = 779) died. Conclusion 83.41% pregnant women were asymptomatic. COVID-19 infection in obstetric cases from India led to 59.01% LSCS procedures which are lower than many other countries. COVID-19 infection led to a higher maternal mortality and IUFD rate as compared to pregnant women that did not have COVID-19 infection in India. Vertical transmission rate is 2.99% and at par with other countries.
Collapse
Affiliation(s)
- Alpesh Mahendrabhai Gandhi
- Arihant Women’s Hospital, Ambica Anandmayi Society, Near Over Bridge, Chandlodiya, Near Manikaka Chawk, Chandlodiya, Ahmedabad, Gujarat 382481 India
| | - Atul Morarji Ganatra
- Dr.R.J.Ganatra Nursing Home, Omkar Lal Building, Opposite Mulund West Railway Station, Mulund (West), Mumbai, Maharashtra 400080 India
- Fortis Hospital, Mulund (West), Mumbai, Maharashtra 400080 India
| | - Parikshit Tank
- Ashwini Maternity and Surgical Hospital, Mahatma Gandhi Road, Ghatkopar (East), Mumbai, Maharashtra 400086 India
| |
Collapse
|
6
|
Benlghazi A, Benali S, Bouhtouri Y, Belouad M, Massoudi H, Kouach J. [SARS-CoV-2 infection in pregnant women; epidemiological, clinical, biological and evolutionary profile in 16 cases: the COVID-19 experience in the Moroccan Military Hospital in Benslimane]. Pan Afr Med J 2021; 38:384. [PMID: 34381528 PMCID: PMC8325444 DOI: 10.11604/pamj.2021.38.384.28695] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2021] [Accepted: 04/01/2021] [Indexed: 12/20/2022] Open
Abstract
The first cases of infection caused by new SARS-CoV-2 coronavirus were reported in China in December 2019. This disease is called COVID-19 and has been declared as a pandemic by the WHO three months after its outbreak (in March 2020). In most cases it results in non-severe infectious syndrome associated with different degrees of benign symptoms (fever, cough, myalgia, headache and potential digestive disorders). SARS-CoV-2 can cause severe lung diseased and, sometimes, it results in death. Data on its consequences during pregnancy are limited. Currently, data on SARS-CoV-2 infection are reassuring and don´t indicate a higher risk of infection or a superimposed risk of complications in pregnant women compared to the general population. A few exceptional cases of maternal mortality have been reported, but they occur, most often, in patients with other diseases, in particular pre-eclampsia. This retrospective study highlights the clinical, biological and evolutionary materno-fetal data collected in the COVID-19 Military Field Hospital of Benslimane, Morocco, over a period of 3 months, from 21st July to 21 October 2020.
Collapse
Affiliation(s)
- Abdelhamid Benlghazi
- Service de Gynécologie-Obstétrique, Hôpital Militaire d'Instruction Mohamed V, Université Mohammed V Rabat, Rabat, Maroc
| | - Saad Benali
- Service de Gynécologie-Obstétrique, Hôpital Militaire d'Instruction Mohamed V, Université Mohammed V Rabat, Rabat, Maroc
| | - Yassine Bouhtouri
- Service de Gynécologie-Obstétrique, Hôpital Militaire d'Instruction Mohamed V, Université Mohammed V Rabat, Rabat, Maroc
| | - Moad Belouad
- Service de Gynécologie-Obstétrique, Hôpital Militaire d'Instruction Mohamed V, Université Mohammed V Rabat, Rabat, Maroc
| | - Hamza Massoudi
- Service de Gynécologie-Obstétrique, Hôpital Militaire d'Instruction Mohamed V, Université Mohammed V Rabat, Rabat, Maroc
| | - Jaouad Kouach
- Service de Gynécologie-Obstétrique, Hôpital Militaire d'Instruction Mohamed V, Université Mohammed V Rabat, Rabat, Maroc
| |
Collapse
|
7
|
Grünebaum A, Chervenak FA, McCullough LB, Dudenhausen JW, Bornstein E, Mackowiak PA. How fever is defined in COVID-19 publications: a disturbing lack of precision. J Perinat Med 2021; 49:255-261. [PMID: 33554570 DOI: 10.1515/jpm-2020-0546] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2020] [Accepted: 12/05/2020] [Indexed: 12/15/2022]
Abstract
OBJECTIVES Fever is the single most frequently reported manifestation of COVID-19 and is a critical element of screening persons for COVID-19. The meaning of "fever" varies depending on the cutoff temperature used, the type of thermometer, the time of the day, the site of measurements, and the person's gender and race. The absence of a universally accepted definition for fever has been especially problematic during the current COVID-19 pandemic. METHODS This investigation determined the extent to which fever is defined in COVID-19 publications, with special attention to those associated with pregnancy. RESULTS Of 53 publications identified in which "fever" is reported as a manifestation of COVID-19 illness, none described the method used to measure patient's temperatures. Only 10 (19%) publications specified the minimum temperature used to define a fever with values that varied from a 37.3 °C (99.1 °F) to 38.1 °C (100.6 °F). CONCLUSIONS There is a disturbing lack of precision in defining fever in COVID-19 publications. Given the many factors influencing temperature measurements in humans, there can never be a single, universally accepted temperature cut-off defining a fever. This clinical reality should not prevent precision in reporting fever. To achieve the precision and improve scientific and clinical communication, when fever is reported in clinical investigations, at a minimum the cut-off temperature used in determining the presence of fever, the anatomical site at which temperatures are taken, and the instrument used to measure temperatures should each be described. In the absence of such information, what is meant by the term "fever" is uncertain.
Collapse
Affiliation(s)
- Amos Grünebaum
- Department of Obstetrics & Gynecology, Lenox Hill Hospital, New York, NY, USA
- Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA
| | - Frank A Chervenak
- Department of Obstetrics & Gynecology, Lenox Hill Hospital, New York, NY, USA
- Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA
| | - Laurence B McCullough
- Department of Obstetrics & Gynecology, Lenox Hill Hospital, New York, NY, USA
- Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA
| | - Joachim W Dudenhausen
- Faculty of Health Sciences, Joint Faculty of University Potsdam, B-TU and MHB, Germany
| | - Eran Bornstein
- Department of Obstetrics & Gynecology, Lenox Hill Hospital, New York, NY, USA
- Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA
| | - Philip A Mackowiak
- Department of Medicine, University of Maryland School of Medicine, Emeritus Professor of Medicine and the Carolyn Frenkil and Selvin Passen History of Medicine Scholar-in-Residence at the University of Maryland School of Medicine, Baltimore, ML, USA
| |
Collapse
|
8
|
Ortega MA, Fraile-Martínez O, García-Montero C, García-Gallego S, Sánchez-Trujillo L, Torres-Carranza D, Álvarez-Mon MÁ, Pekarek L, García-Honduvilla N, Bujan J, Álvarez-Mon M, Asúnsolo Á, De La Torre B. An integrative look at SARS‑CoV‑2 (Review). Int J Mol Med 2021; 47:415-434. [PMID: 33416095 PMCID: PMC7797443 DOI: 10.3892/ijmm.2020.4828] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2020] [Accepted: 12/04/2020] [Indexed: 02/06/2023] Open
Abstract
SARS‑CoV‑2 is a newly discovered member of the betacoronaviruses and the etiological agent of the disease COVID‑19. SARS‑CoV‑2 is responsible for the worldwide pandemic which has been taking place in 2020, and is causing a markedly higher number of infections and deaths compared to previous coronaviruses, such as SARS‑CoV or MERS‑CoV. Based on updated scientific literature, the present review compiles the most relevant knowledge of SARS‑CoV‑2, COVID‑19 and the clinical and typical responses that patients have exhibited against this virus, discussing current and future therapies, and proposing strategies with which to combat the disease and prevent a further global threat. The aggressiveness of SARS‑CoV‑2 arises from its capacity to infect, and spread easily and rapidly through its tight interaction with the human angiotensin‑converting enzyme 2 (ACE‑2) receptor. While not all patients respond in a similar manner and may even be asymptomatic, a wide range of manifestations associated with COVID‑19 have been described, particularly in vulnerable population groups, such as the elderly or individuals with other underlying conditions. The proper function of the immune system plays a key role in an individual's favorable response to SARS‑CoV‑2 infection. A hyperactivated response, on the contrary, could account for the more severe cases of COVID‑19, and this may finally lead to respiratory insufficiency and other complications, such as thrombotic or thromboembolic events. The development of novel therapies and vaccines designed to control and regulate a proper immune system response will be key to clinical management, prevention measures and effective population screening to attenuate the transmission of this novel RNA virus.
Collapse
Affiliation(s)
- Miguel A. Ortega
- Department of Medicine and Medical Specialties, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, 28801 Madrid
- Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid
- Tumor Registry, Pathological Anatomy Service, Prince of Asturias University Hospital, Alcalá de Henares, 28801 Madrid
| | - Oscar Fraile-Martínez
- Department of Medicine and Medical Specialties, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, 28801 Madrid
| | - Cielo García-Montero
- Department of Medicine and Medical Specialties, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, 28801 Madrid
| | - Sandra García-Gallego
- Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid
- Department of Organic and Inorganic Chemistry, 'Andrés M. del Río' Institute of Chemistry (IQAR), University of Alcalá, CIBER-BBN, 28805 Madrid
| | - Lara Sánchez-Trujillo
- Department of Medicine and Medical Specialties, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, 28801 Madrid
- Tumor Registry, Pathological Anatomy Service, Prince of Asturias University Hospital, Alcalá de Henares, 28801 Madrid
| | | | - Miguel Ángel Álvarez-Mon
- Department of Medicine and Medical Specialties, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, 28801 Madrid
- Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid
- Department of Psychiatry and Medical Psychology, Infanta Leonor University Hospital, 28031 Madrid
| | - Leonel Pekarek
- Department of Medicine and Medical Specialties, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, 28801 Madrid
| | - Natalio García-Honduvilla
- Department of Medicine and Medical Specialties, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, 28801 Madrid
- Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid
| | - Julia Bujan
- Department of Medicine and Medical Specialties, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, 28801 Madrid
- Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid
| | - Melchor Álvarez-Mon
- Department of Medicine and Medical Specialties, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, 28801 Madrid
- Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid
- Internal Medicine Service, Prince of Asturias University Hospital, CIBEREHD, Alcalá de Henares, 28805 Madrid
| | - Ángel Asúnsolo
- Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid
- Preventive Medicine and Public Health Area, Department of Surgery, Medical and Social Sciences, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, 28801 Madrid, Spain
- Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, New York University, New York, NY 10027, USA
| | - Basilio De La Torre
- Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid
- Preventive Medicine and Public Health Area, Department of Surgery, Medical and Social Sciences, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, 28801 Madrid, Spain
- Traumatology Service, Ramón y Cajal University Hospital, 28034 Madrid, Spain
| |
Collapse
|
9
|
Shewasinad Yehualashet S, Asefa KK, Mekonnen AG, Gemeda BN, Shiferaw WS, Aynalem YA, Bilchut AH, Derseh BT, Mekuria AD, Mekonnen WN, Meseret WA, Tegegnework SS, Abosetegn AE. Predictors of adherence to COVID-19 prevention measure among communities in North Shoa Zone, Ethiopia based on health belief model: A cross-sectional study. PLoS One 2021; 16:e0246006. [PMID: 33481962 PMCID: PMC7822535 DOI: 10.1371/journal.pone.0246006] [Citation(s) in RCA: 55] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2020] [Accepted: 01/12/2021] [Indexed: 12/16/2022] Open
Abstract
INTRODUCTION Coronavirus disease 2019 (COVID-19) is an emerging respiratory infections and is known to cause illness ranging from the common cold to severe acute respiratory syndrome. At present, the disease has been posing a serious threat to the communities, and it is critical to know the communities' level of adherence on COVID-19 prevention measures. Thus, this study aimed to identify the predictors of adherence to COVID-19 prevention measure among communities in North Shoa zone, Ethiopia by using a health belief model. METHODS Community-based cross-sectional study design was employed. A total of 683 respondents were interviewed using a structured and pre-tested questionnaire. The data were collected by using a mobile-based application called "Google form." Logistic regression was performed to analyze the data. Estimates were reported in adjusted odds ratios with 95% confidence intervals (CI) and a significant association was declared at p-value of less than 0.05. RESULT The overall adherence level of the community towards the recommended safety measures of COVID-19 was 44.1%. Self-efficacy (AOR = 0.23; 95% 0.14, 0.36), perceived benefits (AOR = 0.35; 95% 0.23, 0.56), perceived barriers (AOR = 3.36; 95% 2.23, 5.10), and perceived susceptibility of COVID-19 (AOR = 1.60; 95% 1.06, 2.39) were important predictors that influenced the adherence of the community to COVID-19 preventive behaviors. CONCLUSIONS In this study, the overall adherence level of the community towards the recommended safety measures of COVID-19 was relatively low. It is vital to consider the communities' self-efficacy, perceived benefits, perceived barriers and perceived susceptibility of COVID-19 in order to improve the adherence of the community towards the recommended safety measures of COVID-19.
Collapse
Affiliation(s)
- Sisay Shewasinad Yehualashet
- Department of Nursing, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| | - Kokebe Kefelegn Asefa
- Department of Nursing, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| | - Alemayehu Gonie Mekonnen
- Department of Nursing, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| | - Belete Negess Gemeda
- Department of Nursing, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| | - Wondimenh Shibabaw Shiferaw
- Department of Nursing, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| | - Yared Asmare Aynalem
- Department of Nursing, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| | - Awraris Hailu Bilchut
- Department of Public health, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| | - Behailu Tariku Derseh
- Department of Public health, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| | - Abinet Dagnaw Mekuria
- Department of Public health, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| | - Wassie Negash Mekonnen
- Department of Public health, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| | - Wondesen Asegidew Meseret
- Department of Public health, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| | - Sisay Shine Tegegnework
- Department of Public health, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| | - Akine Eshete Abosetegn
- Department of Public health, College of Health Science, Debre Berhan University, Debre Berhan, Amhara Regional State, Ethiopia
| |
Collapse
|
10
|
Gebru AA, Birhanu T, Wendimu E, Ayalew AF, Mulat S, Abasimel HZ, Kazemi A, Tadesse BA, Gebru BA, Deriba BS, Zeleke NS, Girma AG, Munkhbat B, Yusuf QK, Luke AO, Hailu D. The level of risk, effects response to potential health emergencies, prevention and control method of COVID-19: A systematic review. Hum Antibodies 2021; 29:149-169. [PMID: 32865183 DOI: 10.3233/hab-200421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
BACKGROUND COVID-19 is currently the major public health burden in the world, with disease and death in the global community from COVID-19 increasing rapidly from time to time worldwide. However, there has been a lack of well-organized information about the level of risk, effects, prevention and control methods of the disease. Therefore the aim of this study is to identify and review a published level of risk, effects response to potential health emergencies, prevention, and control methods of COVID-19 at a global level. METHOD A systematic review was performed after literatures were identified by searching the following online databases: medRxiv, Google scholar, PubMed, MEDLINE, EMBASE, and the Cochrane Library with supplementary hand searching of conferences. The online databases contain archives of most English biomedical journals. Scientific papers published online by the Center for Disease Control and the World Health Organization were also included for this analysis. The scientific publications from 01 December, 2019 to 13 April 2020 were included. The 'COVID-19', '2019 novel coronavirus', '2019-nCoV', 'novel coronavirus', and 'Pneumonia' key search terms were used for this review.
Collapse
Affiliation(s)
- Addis Adera Gebru
- International Relation Directorate Director, Salale University, Fitche, Ethiopia
- Department of Public Health, Reft Valley University, College of Health Sciences, Abichu Campus, Addis Ababa, Ethiopia
- Department of Public Health, College of Health Sciences, Kotebe Metropolitan University, Addis Ababa, Ethiopia
| | - Tadesse Birhanu
- Department of Animal Sciences (Specialist on Infectious Diseases), College of Agriculture and Natural Resources, Salale University, Fitche, Ethiopia
| | - Eshetu Wendimu
- Research and Community Services Vice President, Salale University, Fitche, Ethiopia
| | - Agumas Fentahun Ayalew
- Department of Public Health, College of Health Sciences, Woldia University, Woldia, Ethiopia
| | - Selamawit Mulat
- Injibara Woreda Health Office, Regulatory Officer, Injibara, Ethiopia
| | - Hussen Zakir Abasimel
- Department of Midwifery, College of Health Sciences, Salale University, Fitche, Ethiopia
| | - Ali Kazemi
- Department of Health Economics, School of Public Health, Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Bosenu Abera Tadesse
- Department of Animal Sciences, College of Agriculture and Natural Resources, Salale University, Fitche, Ethiopia
| | - Beniam Adera Gebru
- Addis Ababa City Adminstration Public Procurement and Materials, Addis Ababa, Ethiopia
| | - Berhanu Senbeta Deriba
- Department of Public Health, College of Health Sciences, Salale University, Fitche, Ethiopia
| | - Nigus Shimelis Zeleke
- Department of Sociology, College of Social Sciences and Humanities, Salale University, Fitche, Ethiopia
| | - Abebe Gule Girma
- Department of Animal Sciences (Specialist on Infectious Diseases), College of Agriculture and Natural Resources, Salale University, Fitche, Ethiopia
| | - Bulgantsetseg Munkhbat
- Department of Animal Sciences (Specialist on Infectious Diseases), College of Agriculture and Natural Resources, Salale University, Fitche, Ethiopia
| | | | - Amana Ogeto Luke
- Department of Public Health, Reft Valley University, College of Health Sciences, Abichu Campus, Addis Ababa, Ethiopia
| | - Dejene Hailu
- Department of Nursing, College of Health Sciences
| |
Collapse
|
11
|
Peyronnet V, Sibiude J, Huissoud C, Lescure FX, Lucet JC, Mandelbrot L, Nisand I, Belaish-Allart J, Vayssière C, Yazpandanah Y, Luton D, Picone O. [Infection with SARS-CoV-2 in pregnancy. Update of Information and proposed care. CNGOF]. GYNECOLOGIE, OBSTETRIQUE, FERTILITE & SENOLOGIE 2020; 48:858-870. [PMID: 33031963 PMCID: PMC7534662 DOI: 10.1016/j.gofs.2020.10.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
OBJECTIVES The coronavirus SARS-CoV-2 identified late 2019 in China had spread across all continents. In the majority of cases, patients have mild symptoms (fever, cough, myalgia, headache, some digestive disorders) or are asymptomatic, however it can cause serious lung diseases and lead to death. On September 2020, over 28 million people have been infected with over 920,000 deaths. METHODS In view of the evolution of the epidemic the French National College of Obstetricians and Gynecologists has decided to update the recommendations previously issued. To do this, the same group of experts was called upon to carry out a review of the literature and take into account the opinions of the General Directorate of Health (DGS), the "Haute Autorité de Santé" (HAS) and the "Haut Conseil de santé Publique" (HCSP). RESULTS The data on consequences during pregnancy have accumulated. The symptoms in pregnant women appear to be similar to those of the general population, but an increased risk of respiratory distress exists in pregnant women especially in the third trimester. A case of intrauterine maternal-fetal transmission has been clearly identified. Induced prematurity and cases of respiratory distress in newborns of infected mothers have been described. CONCLUSION In light of the new data, we propose updated recommendations. These proposals may continue to evolve in view of the pandemic and of advances in studies in pregnant women.
Collapse
Affiliation(s)
- V Peyronnet
- Service de gynécologie-obstétrique, hôpital Louis-Mourier, Assistance publique-Hôpitaux de Paris, 92700 Colombes, France
| | - J Sibiude
- Service de gynécologie-obstétrique, hôpital Louis-Mourier, Assistance publique-Hôpitaux de Paris, 92700 Colombes, France; Inserm IAME-U1137, 75000 Paris, France; Groupe de recherche sur les infections pendant la grossesse (GRIG), 75000 Paris, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France
| | - C Huissoud
- University Lyon, University Claude Bernard, 69000 Lyon, France; Hôpital de la Croix-Rousse, hospices civils de Lyon, 69004 Lyon, France; Inserm U846, stem cell and brain research institute, 18, avenue Doyen-Lepine, 69500 Bron, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France
| | - F-X Lescure
- Inserm IAME-U1137, 75000 Paris, France; Service de maladies infectieuses et tropicales, hôpital Bichat Claude-Bernard, université de Paris, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France
| | - J-C Lucet
- Inserm IAME-U1137, 75000 Paris, France
| | - L Mandelbrot
- Service de gynécologie-obstétrique, hôpital Louis-Mourier, Assistance publique-Hôpitaux de Paris, 92700 Colombes, France; Inserm IAME-U1137, 75000 Paris, France; Groupe de recherche sur les infections pendant la grossesse (GRIG), 75000 Paris, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France
| | - I Nisand
- CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France
| | | | - C Vayssière
- Hôpital Paule-de-Viguier, CHU de Toulouse, 31000 Toulouse, France; Inserm UMR1027, équipe SPHERE, université Toulouse III, 31000 Toulouse, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France
| | - Y Yazpandanah
- Inserm IAME-U1137, 75000 Paris, France; Service de maladies infectieuses et tropicales, hôpital Bichat Claude-Bernard, université de Paris, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France
| | - D Luton
- FHU Prematurity Inserm U1016, service de gynécologie obstétrique, maternité Aline de Crepy, hôpital Bichat, institut IMAGINE, université de Paris, AP-HP, 75018 Paris, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France
| | - O Picone
- Service de gynécologie-obstétrique, hôpital Louis-Mourier, Assistance publique-Hôpitaux de Paris, 92700 Colombes, France; Inserm IAME-U1137, 75000 Paris, France; Groupe de recherche sur les infections pendant la grossesse (GRIG), 75000 Paris, France; CNGOF, 91, boulevard de Sébastopol, 75002 Paris, France.
| |
Collapse
|
12
|
Wang MY, Zhao R, Gao LJ, Gao XF, Wang DP, Cao JM. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development. Front Cell Infect Microbiol 2020; 10:587269. [PMID: 33324574 PMCID: PMC7723891 DOI: 10.3389/fcimb.2020.587269] [Citation(s) in RCA: 463] [Impact Index Per Article: 115.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2020] [Accepted: 10/26/2020] [Indexed: 01/18/2023] Open
Abstract
The pandemic of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been posing great threats to the world in many aspects. Effective therapeutic and preventive approaches including drugs and vaccines are still unavailable although they are in development. Comprehensive understandings on the life logic of SARS-CoV-2 and the interaction of the virus with hosts are fundamentally important in the fight against SARS-CoV-2. In this review, we briefly summarized the current advances in SARS-CoV-2 research, including the epidemic situation and epidemiological characteristics of the caused disease COVID-19. We further discussed the biology of SARS-CoV-2, including the origin, evolution, and receptor recognition mechanism of SARS-CoV-2. And particularly, we introduced the protein structures of SARS-CoV-2 and structure-based therapeutics development including antibodies, antiviral compounds, and vaccines, and indicated the limitations and perspectives of SARS-CoV-2 research. We wish the information provided by this review may be helpful to the global battle against SARS-CoV-2 infection.
Collapse
Affiliation(s)
| | | | | | | | - De-Ping Wang
- Key Laboratory of Cellular Physiology at Shanxi Medical University, Ministry of Education, Key Laboratory of Cellular Physiology of Shanxi Province, and the Department of Physiology, Shanxi Medical University, Taiyuan, China
| | - Ji-Min Cao
- Key Laboratory of Cellular Physiology at Shanxi Medical University, Ministry of Education, Key Laboratory of Cellular Physiology of Shanxi Province, and the Department of Physiology, Shanxi Medical University, Taiyuan, China
| |
Collapse
|
13
|
Paliwal VK, Garg RK, Gupta A, Tejan N. Neuromuscular presentations in patients with COVID-19. Neurol Sci 2020; 41:3039-3056. [PMID: 32935156 PMCID: PMC7491599 DOI: 10.1007/s10072-020-04708-8] [Citation(s) in RCA: 152] [Impact Index Per Article: 38.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Accepted: 09/01/2020] [Indexed: 12/20/2022]
Abstract
COVID-19 is caused by the coronavirus SARS-CoV-2 that has an affinity for neural tissue. There are reports of encephalitis, encephalopathy, cranial neuropathy, Guillain-Barrè syndrome, and myositis/rhabdomyolysis in patients with COVID-19. In this review, we focused on the neuromuscular manifestations of SARS-CoV-2 infection. We analyzed all published reports on SARS-CoV-2-related peripheral nerve, neuromuscular junction, muscle, and cranial nerve disorders. Olfactory and gustatory dysfunction is now accepted as an early manifestation of COVID-19 infection. Inflammation, edema, and axonal damage of olfactory bulb have been shown in autopsy of patients who died of COVID-19. Olfactory pathway is suggested as a portal of entry of SARS-CoV-2 in the brain. Similar to involvement of olfactory bulb, isolated oculomotor, trochlear and facial nerve has been described. Increasing reports Guillain-Barrè syndrome secondary to COVID-19 are being published. Unlike typical GBS, most of COVID-19-related GBS were elderly, had concomitant pneumonia or ARDS, more prevalent demyelinating neuropathy, and relatively poor outcome. Myalgia is described among the common symptoms of COVID-19 after fever, cough, and sore throat. Duration of myalgia may be related to the severity of COVID-19 disease. Few patients had muscle weakness and elevated creatine kinase along with elevated levels of acute-phase reactants. All these patients with myositis/rhabdomyolysis had severe respiratory complications related to COVID-19. A handful of patients with myasthenia gravis showed exacerbation of their disease after acquiring COVID-19 disease. Most of these patients recovered with either intravenous immunoglobulins or steroids.
Collapse
Affiliation(s)
- Vimal Kumar Paliwal
- Department of Neurology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP 226014 India
| | | | - Ankit Gupta
- Department of Neurology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP 226014 India
| | - Nidhi Tejan
- Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP 226014 India
| |
Collapse
|
14
|
Fouogue JT, Noubom M, Kenfack B, Dongmo NT, Tabeu M, Megozeu L, Alima JM, Fogang YF, Nyam LCRA, Fouelifack FY, Fouedjio JH, Manebou PLFN, Bibou Ze CD, Kouam BF, Fomete LN, Tebeu PM, Kemfang JDN, Foumane P, Sando Z, Orock GEE. Poor knowledge of COVID-19 and unfavourable perception of the response to the pandemic by healthcare workers at the Bafoussam Regional Hospital (West Region-Cameroon). Pan Afr Med J 2020; 37:19. [PMID: 33343798 PMCID: PMC7733347 DOI: 10.11604/pamj.supp.2020.37.19.25688] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2020] [Accepted: 09/14/2020] [Indexed: 12/18/2022] Open
Abstract
INTRODUCTION WHO warned against a dramatic impact of COVID-19 in Africa unless adequate response strategies are implemented. Whatever the strategy, the role of health staff is pivotal. Objective: Assess knowledge and perception of the response to COVID-19 among health staff. METHODS we used a convenience non probabilistic sample to conduct a survey with a self-administered questionnaire from April 14 - 29, 2020 at the Bafoussam Regional Hospital (BRH). All the staff was invited to participate. Analyses were done with Microsoft Excel 2010 and Epi-Info version 7.1.5.2. RESULTS response rate was 76.1% (464/610). Mean age (SD) was 35.0 (8.9) years. Sex ratio (M/F) was 101/356. Nursing/midwifery staff (56.8%) and in-patients units (49.94%) were predominant. Origin and transmission of SARS-CoV-2 were poorly known while knowledge of clinical signs and the role of laboratory tests were good. For 53.2% of respondents all therapeutic regimens are supportive and only 31.6% trusted state-recommended drugs. For 169 of respondents (36.9%), herbal remedies prevent/cure COVID-19. Seventy percent (70%) felt they were not knowledgeable enough to handle COVID-19 cases. Eighty-five point six percent (85.6%) thought the BRH had insufficient resources to fight COVID-19 and 55.6% were dissatisfied with its response (weaknesses: medicines/technologies (74.5%), service delivery (28.1%), staff (10.9%)). Sixty-eight percent (68%) reported insufficient protection on duty. Seventy-six point five percent (76.5%) reported a drop in non-COVID-19 services. Eighty-five point five (85.5%) percent said they complied with community preventive measures. For 44% of respondents, regulations on COVID-19 corpses should be made more culture-sensitive. Fifty one point two percent (51.2%) of respondents were against vaccine trial in their community. CONCLUSION knowledge was poor and perception of the response to COVID-19 was unfavourable.
Collapse
Affiliation(s)
- Jovanny Tsuala Fouogue
- Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, West Region, Cameroon
- Bafoussam Regional Hospital, Bafoussam, West Region, Cameroon
| | - Michel Noubom
- Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, West Region, Cameroon
- Bafoussam Regional Hospital, Bafoussam, West Region, Cameroon
| | - Bruno Kenfack
- Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, West Region, Cameroon
| | | | - Maxime Tabeu
- Bafoussam Regional Hospital, Bafoussam, West Region, Cameroon
| | - Linda Megozeu
- Bafoussam Regional Hospital, Bafoussam, West Region, Cameroon
| | | | - Yannick Fogoum Fogang
- Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, West Region, Cameroon
- Bafoussam Regional Hospital, Bafoussam, West Region, Cameroon
| | | | | | | | | | | | | | - Lauriane Nomene Fomete
- Agence Nationale de Recherche sur le Sida et les Hépatite Virales - Site Cameroun, Yaoundé, Centre Region, Cameroon
| | - Pierre Marie Tebeu
- Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon
| | | | - Pascal Foumane
- Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon
| | - Zacharie Sando
- Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon
| | | |
Collapse
|
15
|
Vivanti AJ, Deruelle P, Picone O, Guillaume S, Roze JC, Mulin B, Kochert F, De Beco I, Mahut S, Gantois A, Barasinski C, Petitprez K, Pauchet-Traversat AF, Droy A, Benachi A. Follow-up for pregnant women during the COVID-19 pandemic: French national authority for health recommendations. J Gynecol Obstet Hum Reprod 2020; 49:101804. [PMID: 32407897 PMCID: PMC7212959 DOI: 10.1016/j.jogoh.2020.101804] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
INTRODUCTION In the context of the stage 3 SARS-Cov-2 epidemic situation, it is necessary to put forward a method of rapid response for an HAS position statement in order to answer to the requests from the French Ministry of Solidarity and Health, healthcare professionals and/or health system users' associations concerning follow-up of pregnant women during the COVID-19 outbreak. METHODS A simplified 7-step process that favours HAS collaboration with experts (healthcare professionals, health system users' associations, scientific societies etc.), the restrictive selection of available evidence and the use of digital means of communication. A short and specific dissemination format, which can be quickly updated in view of the changes in available data has been chosen.
Collapse
Affiliation(s)
- Alexandre J Vivanti
- Service de Gynécologie Obstétrique, Hôpital Antoine Béclère, AP-HP, Université Paris-Saclay, 92140 Clamart, France.
| | - Philippe Deruelle
- Collège National des Gynécologues Obstétriciens Français, 75002 Paris, France; Service de Gynécologie Obstétrique, Hôpital de Hautepierre, Faculté de Médecine de Strasbourg, 67000 Strasbourg, France
| | - Olivier Picone
- Collège National des Gynécologues Obstétriciens Français, 75002 Paris, France; Division of Obstetrics and Gynecology, "Louis Mourier" Hospital, Paris University, IAME INSERM U1137, APHP (Paris, France) GRIG (Groupe de Recherche sur les Infections pendant la Grossesse), 92700 Colombes
| | - Sophie Guillaume
- Collège National des Sages-Femmes de France, 75015 Paris, France
| | | | - Blandine Mulin
- French Federation of Perinatal Health Networks, 31000 Toulouse, France
| | - Fabienne Kochert
- French Association of Ambulatory Paediatrics, 33400 Talence, France
| | | | - Sophie Mahut
- College of General Medicine, 75017 Paris 8, France
| | - Adrien Gantois
- Collège National des Sages-Femmes de France, 75015 Paris, France
| | - Chloé Barasinski
- Collège National des Sages-Femmes de France, 75015 Paris, France; Université Clermont Auvergne, CNRS, CHU Clermont-Ferrand, SIGMA, INSTITUT PASCAL, F63000 ClermontFerrand, France
| | - Karine Petitprez
- Guidelines Department, French National Authority for Health, 93200 Saint-Denis, France
| | | | - Alcyone Droy
- Guidelines Department, French National Authority for Health, 93200 Saint-Denis, France
| | - Alexandra Benachi
- Service de Gynécologie Obstétrique, Hôpital Antoine Béclère, AP-HP, Université Paris-Saclay, 92140 Clamart, France; Collège National des Gynécologues Obstétriciens Français, 75002 Paris, France
| |
Collapse
|
16
|
Faure‐Bardon V, Salomon LJ, Leruez‐Ville M, Ville Y. How should we treat pregnant women infected with SARS-CoV-2? BJOG 2020; 127:1050-1052. [PMID: 32324956 PMCID: PMC7264541 DOI: 10.1111/1471-0528.16270] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/20/2020] [Indexed: 12/15/2022]
Affiliation(s)
- V Faure‐Bardon
- EA 73‐28Paris Descartes UniversitySorbonne Paris CitéParisFrance
- MaternityAP‐HP, Hospital Necker‐E.M.ParisFrance
| | - LJ Salomon
- EA 73‐28Paris Descartes UniversitySorbonne Paris CitéParisFrance
- MaternityAP‐HP, Hospital Necker‐E.M.ParisFrance
| | - M Leruez‐Ville
- MaternityAP‐HP, Hospital Necker‐E.M.ParisFrance
- Virology LaboratoryAP‐HP, Hospital Necker‐E.M.ParisFrance
| | - Y Ville
- EA 73‐28Paris Descartes UniversitySorbonne Paris CitéParisFrance
- MaternityAP‐HP, Hospital Necker‐E.M.ParisFrance
| |
Collapse
|
17
|
Examining the Impact of the 2019 Novel Coronavirus and Pandemic-Related Hardship on Adverse Pregnancy and Infant Outcomes: Design and Launch of the HOPE COVID-19 Study. REPRODUCTIVE MEDICINE 2020. [DOI: 10.3390/reprodmed1020007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
The 2019 novel coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread and worsen in many parts of the world. As the pandemic grows, it is especially important to understand how the virus and the pandemic are affecting pregnant women and infants. While early data suggested that being infected with the virus did not increase the risk of adverse pregnancy or infant outcomes, as more information has emerged, it has become clear that risks for some adverse pregnancy and infant outcomes are increased (e.g., preterm birth, cesarean section, respiratory distress, and hospitalization). The Healthy Outcomes of Pregnancy for Everyone in the time of novel coronavirus disease-19 (HOPE COVID-19) study is a multi-year, prospective investigation designed to better understand how the SARS-CoV-2 virus and COVID-19 impact adverse pregnancy and infant outcomes. The study also examines how the pandemic exacerbates existing hardships such as social isolation, economic destabilization, job loss, housing instability, and/or family member sickness or death among minoritized and marginalized communities. Specifically, the study examines how pandemic-related hardships impact clinical outcomes and characterizes the experiences of Black, Latinx and low-income groups compared to those in other race/ethnicity and socioeconomic stratum. The study includes two nested cohorts. The survey only cohort will enroll 7500 women over a two-year period. The survey+testing cohort will enroll 2500 women over this same time period. Participants in both cohorts complete short surveys daily using a mobile phone application about COVID-19-related symptoms (e.g., fever and cough) and complete longer surveys once during each trimester and at 6–8 weeks and 6, 12 and 18 months after delivery that focus on the health and well-being of mothers and, after birth, of infants. Participants in the survey+testing cohort also have testing for SARS-CoV-2 and related antibodies during pregnancy and after birth as well as testing that looks at inflammation and for the presence of other infections like Influenza and Rhinovirus. Study results are expected to be reported on a rolling basis and will include quarterly reporting for participants and public health partners as well as more traditional scientific reporting.
Collapse
|
18
|
Technics to put on and remove personal protective equipment before surgical or obstetrical procedure in suspected or infected COVID-19 patients (with video). J Gynecol Obstet Hum Reprod 2020; 49:101859. [PMID: 32652303 PMCID: PMC7345405 DOI: 10.1016/j.jogoh.2020.101859] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2020] [Revised: 07/03/2020] [Accepted: 07/04/2020] [Indexed: 12/17/2022]
Abstract
Coronavirus pandemic is widely changing our professional daily practice and preventive measures must be taken and taught. Before any planned gynaecological or obstetric surgery, specific technics to put on and safely remove personal protective equipment should be implemented in order to avoid any contamination for both patients and healthcare workers.
Collapse
|
19
|
Alberca RW, Pereira NZ, Oliveira LMDS, Gozzi-Silva SC, Sato MN. Pregnancy, Viral Infection, and COVID-19. Front Immunol 2020; 11:1672. [PMID: 32733490 PMCID: PMC7358375 DOI: 10.3389/fimmu.2020.01672] [Citation(s) in RCA: 56] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Accepted: 06/23/2020] [Indexed: 12/14/2022] Open
Abstract
Pregnancy comprises a unique immunological condition, to allow fetal development and to protect the host from pathogenic infections. Viral infections during pregnancy can disrupt immunological tolerance and may generate deleterious effects on the fetus. Despite these possible links between pregnancy and infection-induced morbidity, it is unclear how pregnancy interferes with maternal response to some viral pathogens. In this context, the novel coronavirus (SARS-CoV-2) can induce the coronavirus diseases-2019 (COVID-19) in pregnant women. The potential risk of vertical transmission is unclear, babies born from COVID-19-positive mothers seems to have no serious clinical symptoms, the possible mechanisms are discussed, which highlights that checking the children's outcome and more research is warranted. In this review, we investigate the reports concerning viral infections and COVID-19 during pregnancy, to establish a correlation and possible implications of COVID-19 during pregnancy and neonatal's health.
Collapse
MESH Headings
- Betacoronavirus
- COVID-19
- Child, Preschool
- Coronavirus Infections/blood
- Coronavirus Infections/immunology
- Coronavirus Infections/transmission
- Coronavirus Infections/virology
- Cytokines/blood
- Female
- Fetal Development/immunology
- Humans
- Infant
- Infant, Newborn
- Infectious Disease Transmission, Vertical
- Mothers
- Pandemics
- Pneumonia, Viral/blood
- Pneumonia, Viral/immunology
- Pneumonia, Viral/transmission
- Pneumonia, Viral/virology
- Pregnancy
- Pregnancy Complications, Infectious/blood
- Pregnancy Complications, Infectious/immunology
- Pregnancy Complications, Infectious/virology
- SARS-CoV-2
Collapse
Affiliation(s)
- Ricardo Wesley Alberca
- Laboratory of Dermatology and Immunodeficiencies, LIM-56, Department of Dermatology, School of Medicine and Institute of Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil
| | - Nátalli Zanete Pereira
- Laboratory of Dermatology and Immunodeficiencies, LIM-56, Department of Dermatology, School of Medicine and Institute of Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil
| | - Luanda Mara Da Silva Oliveira
- Laboratory of Dermatology and Immunodeficiencies, LIM-56, Department of Dermatology, School of Medicine and Institute of Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil
| | | | - Maria Notomi Sato
- Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
| |
Collapse
|
20
|
Singal CMS, Jaiswal P, Seth P. SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis. ACS Chem Neurosci 2020; 11:1887-1899. [PMID: 32491829 DOI: 10.1021/acschemneuro.0c00251] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
The coronavirus disease-19 (COVID-19) pandemic has emerged as one of the major outbreaks to be mentioned in history in coming times. Like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a respiratory virus infecting the lungs with fever, dry cough, and acute pneumonia being the major symptoms. It infects epithelial cells expressing angiotensin converting enzyme 2 (ACE2) receptor, which is crucial for viral entry. Based on evolving clinical evidence, it is now unfitting to label SARS-CoV-2 as just a respiratory virus, as lately there are various reports that substantiate its pathogenicity in other organs of the body, including brain. In this review, we discuss the epidemiology of SARS-CoV-2 in comparison to SARS and MERS along with possibilities of viral entry into central nervous system (CNS) tissues. The review provides detailed information about the virulence, epidemiology, and insights into molecular pathways involved in the infectivity of the SARS-CoV-2 virus, along with an in-depth view of current concepts about the neurological significance of the SARS-CoV-2 virus and its neuropathological competence. The review also touches upon our current understanding of placental transmission of SARS-CoV-2, an important aspect of vertical transmission. Furthermore, the review provides a current update on strategies that have been used, are being used, or are under trial for treating the disease.
Collapse
Affiliation(s)
| | - Paritosh Jaiswal
- Cellular and Molecular Neuroscience, National Brain Research Centre, Manesar, Gurgaon, Haryana 122052, India
| | | |
Collapse
|
21
|
Egloff C, Vauloup-Fellous C, Picone O, Mandelbrot L, Roques P. Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2. J Clin Virol 2020; 128:104447. [PMID: 32425663 PMCID: PMC7233246 DOI: 10.1016/j.jcv.2020.104447] [Citation(s) in RCA: 77] [Impact Index Per Article: 19.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2020] [Accepted: 05/14/2020] [Indexed: 02/08/2023]
Abstract
While SARS-CoV-2 infection has spread rapidly worldwide, data remains scarce about the natural history of infection in pregnant women and the risk of mother-to-fetal transmission. Current data indicates that viral RNA levels in maternal blood are low and there is no evidence of placental infection with SARS-CoV-2. Published reports to date suggest that perinatal transmission of SARSCoV- 2 can occur but is rare. Among 179 newborns tested for SARS-CoV2 at birth from mothers with COVID-19, transmission was suspected in 8 cases, 5 with positive nasopharyngeal SARS-CoV-2 RT-PCR and 3 with SARS-CoV-2 IgM. However, these cases arise from maternal infection close to childbirth and there are no information about exposition during first or second trimester of pregnancy. Welldesigned prospective cohort studies with rigorous judgement criteria are needed to determine the incidence and risk factors for perinatal transmission of SARS-CoV-2.
Collapse
Affiliation(s)
- Charles Egloff
- Service de gynécologie-obstétrique, Hôpital Louis Mourier, AP-HP, Université de PARIS, IAME INSERM U1137, Paris, France; IDMIT, CEA, IMVA INSERM U1184, Université Paris Saclay, Fontenay aux Roses, France.
| | - Christelle Vauloup-Fellous
- Service de Virologie, Hôpital Paul Brousse, AP-HP, Inserm U 1193, Université Paris Saclay, Villejuif, France
| | - Olivier Picone
- Service de gynécologie-obstétrique, Hôpital Louis Mourier, AP-HP, Université de PARIS, IAME INSERM U1137, Paris, France
| | - Laurent Mandelbrot
- Service de gynécologie-obstétrique, Hôpital Louis Mourier, AP-HP, Université de PARIS, IAME INSERM U1137, Paris, France
| | - Pierre Roques
- IDMIT, CEA, IMVA INSERM U1184, Université Paris Saclay, Fontenay aux Roses, France.
| |
Collapse
|
22
|
Louchet M, Sibiude J, Peytavin G, Picone O, Tréluyer JM, Mandelbrot L. Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019. Am J Obstet Gynecol MFM 2020; 2:100159. [PMID: 32838264 PMCID: PMC7308040 DOI: 10.1016/j.ajogmf.2020.100159] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2020] [Revised: 06/02/2020] [Accepted: 06/07/2020] [Indexed: 12/15/2022]
Abstract
Objective Treatment of coronavirus disease 2019 is mostly symptomatic, but a wide range of medications are under investigation against severe acute respiratory syndrome coronavirus 2. Although pregnant women are excluded from clinical trials, they will inevitably receive therapies whenever they seem effective in nonpregnant patients and even under compassionate use. Methods We conducted a review of the literature on placental transfer and pregnancy safety data of drugs under current investigation for coronavirus disease 2019. Results Regarding remdesivir, there are no data in pregnant women. Several other candidates already have safety data in pregnant women, because they are repurposed drugs already used for their established indications. Thus, they may be used in pregnancy, although their safety in the context of coronavirus disease 2019 may differ from conventional use. These include HIV protease inhibitors such as lopinavir/ritonavir that have low placental transfer, interferon that does not cross the placental barrier, and hydroxychloroquine or chloroquine that has high placental transfer. There are also pregnancy safety and placental transfer data for colchicine, steroids, oseltamivir, azithromycin, and some monoclonal antibodies. However, some drugs are strictly prohibited in pregnancy because of known teratogenicity (thalidomide) or fetal toxicities (renin-angiotensin system blockers). Other candidates including tocilizumab, other interleukin 6 inhibitors, umifenovir, and favipiravir have insufficient data on pregnancy outcomes. Conclusion In life-threatening cases of coronavirus disease 2019, the potential risks of therapy to the fetus may be more than offset by the benefit of curing the mother. Although preclinical and placental transfer studies are required for a number of potential anti-severe acute respiratory syndrome coronavirus 2 drugs, several medications can already be used in pregnant women.
Collapse
Affiliation(s)
- Margaux Louchet
- Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique, Hôpital Louis Mourier, Colombes, France
| | - Jeanne Sibiude
- Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique, Hôpital Louis Mourier, Colombes, France
- Inserm Infection, Antimicrobials, Modelling, Evolution U1137, Paris, France
- Université de Paris, Paris, France
| | | | - Olivier Picone
- Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique, Hôpital Louis Mourier, Colombes, France
- Inserm Infection, Antimicrobials, Modelling, Evolution U1137, Paris, France
- Université de Paris, Paris, France
| | - Jean-Marc Tréluyer
- Université de Paris, Paris, France
- Assistance Publique-Hôpitaux de Paris, Service de Pharmacologie-Toxicologie, Hôpital Bichat, Paris, France; and Assistance Publique-Hôpitaux de Paris, URC/CIC Cochin-Necker, Paris, France
| | - Laurent Mandelbrot
- Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique, Hôpital Louis Mourier, Colombes, France
- Inserm Infection, Antimicrobials, Modelling, Evolution U1137, Paris, France
- Université de Paris, Paris, France
- Corresponding author: Laurent Mandelbrot, MD.
| |
Collapse
|
23
|
Diouf AA, Mbaye KD, Gueye M, Thioub D, Niang N, Dekou CY, Gueye MDN, Diallo M, Mbaye M, Dieme MEF, Diouf A, Seydi M. Clinical characteristics and outcomes of COVID-19 infection in nine pregnant women: a report from a sub-Saharan African country, Senegal. Pan Afr Med J 2020; 35:58. [PMID: 33623583 PMCID: PMC7875754 DOI: 10.11604/pamj.supp.2020.35.2.23736] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2020] [Accepted: 05/28/2020] [Indexed: 12/21/2022] Open
Abstract
Introduction To investigate the clinical characteristics of COVID-19 in pregnancy in Senegal. Methods This was a cross-sectional and descriptive study of all cases of COVID-19 including nine pregnant women who were admitted in COVID-19 treatment centers in Senegal from March 2 to May 15, 2020. SARS-COV-2 infection was confirmed by PCR. Patients’ characteristics, clinical features, treatment and outcome were obtained with a customized data collection form. Results The frequency of the association COVID-19 and pregnancy was 0.5%. The age range of the patients was 18-42 years with an average 28 years, and the range of gestational weeks at admission was 7 weeks to 32 weeks. None of the patients had underlying diseases. All the patients presented with a headache and only four of them had fever. Other symptoms were also observed: two patients had a cough, two had rhinorrhea, and two patients reported poor appetite. The median time to recovery was 13.6 days, corresponding to the number of days in hospital. None of the nine pregnant women developed severe COVID-19 pneumonia or died. Conclusion Pregnant women appear to have the same contamination predispositions and clinical features of SARS-COV-2 infection as the general population. This study shows no evidence that pregnant women are more susceptible to infection with coronavirus.
Collapse
Affiliation(s)
- Abdoul Aziz Diouf
- Department of Gynecology and Obstetrics, Pikine National Hospital Center, Dakar, Senegal
| | | | - Mamour Gueye
- Department of Gynecology and Obstetrics, Philippe Maguilen Senghor Health Center, Dakar, Senegal
| | - Daouda Thioub
- Infectious and Tropical Diseases Department, Fann University Hospital, Dakar, Senegal
| | - Ndama Niang
- Department of Gynecology and Obstetrics, Pikine National Hospital Center, Dakar, Senegal
| | - Christelle Yonta Dekou
- Department of Gynecology and Obstetrics, Tambacounda Regional Hospital, Tambacounda, Senegal
| | - Mame Diarra Ndiaye Gueye
- Department of Gynecology and Obstetrics, Philippe Maguilen Senghor Health Center, Dakar, Senegal
| | - Moussa Diallo
- Department of Gynecology and Obstetrics, Pikine National Hospital Center, Dakar, Senegal
| | - Magatte Mbaye
- Department of Gynecology and Obstetrics, Philippe Maguilen Senghor Health Center, Dakar, Senegal
| | | | - Alassane Diouf
- Department of Gynecology and Obstetrics, Pikine National Hospital Center, Dakar, Senegal
| | - Moussa Seydi
- Infectious and Tropical Diseases Department, Fann University Hospital, Dakar, Senegal
| |
Collapse
|
24
|
Sichitiu J, Desseauve D. Intrapartum care of women with COVID-19: A practical approach. Eur J Obstet Gynecol Reprod Biol 2020; 249:94-95. [PMID: 32307204 PMCID: PMC7195107 DOI: 10.1016/j.ejogrb.2020.04.018] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Revised: 04/01/2020] [Accepted: 04/03/2020] [Indexed: 11/16/2022]
Affiliation(s)
- Joanna Sichitiu
- Women-Mother-Child Department, Centre Hospitalier Universitaire Vaudois, Avenue Pierre-Decker 2, 1011, Lausanne, Switzerland.
| | - David Desseauve
- Women-Mother-Child Department, Centre Hospitalier Universitaire Vaudois, Avenue Pierre-Decker 2, 1011, Lausanne, Switzerland
| |
Collapse
|
25
|
Nohuz E, Dubernard G, Lamblin G, Lebail-Carval K, Chabert P, Chêne G. [Gynecological surgery during the COVID-19 pandemic: Take home messages]. GYNECOLOGIE, OBSTETRIQUE, FERTILITE & SENOLOGIE 2020; 48:526-529. [PMID: 32311508 PMCID: PMC7165081 DOI: 10.1016/j.gofs.2020.04.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/10/2020] [Indexed: 12/15/2022]
Affiliation(s)
- E Nohuz
- Service de gynécologie-obstétrique, hôpital Femme-Mère-Enfant (HFME), hospices civils de Lyon, 59, boulevard Pinel, 69120 Lyon-Bron, France.
| | - G Dubernard
- Service de gynécologie-obstétrique, hôpital de la Croix-Rousse, hospices civils de Lyon, 103, Grande Rue de la Croix-Rousse, 69004 Lyon, France
| | - G Lamblin
- Service de gynécologie-obstétrique, hôpital Femme-Mère-Enfant (HFME), hospices civils de Lyon, 59, boulevard Pinel, 69120 Lyon-Bron, France
| | - K Lebail-Carval
- Service de gynécologie-obstétrique, hôpital Femme-Mère-Enfant (HFME), hospices civils de Lyon, 59, boulevard Pinel, 69120 Lyon-Bron, France
| | - P Chabert
- Service de gynécologie-obstétrique, hôpital Femme-Mère-Enfant (HFME), hospices civils de Lyon, 59, boulevard Pinel, 69120 Lyon-Bron, France
| | - G Chêne
- Service de gynécologie-obstétrique, hôpital Femme-Mère-Enfant (HFME), hospices civils de Lyon, 59, boulevard Pinel, 69120 Lyon-Bron, France; EMR 3738, université Claude-Bernard Lyon 1, 69000 Lyon, France
| |
Collapse
|
26
|
Rafiq D, Batool A, Bazaz MA. Three months of COVID-19: A systematic review and meta-analysis. Rev Med Virol 2020; 30:e2113. [PMID: 32420674 PMCID: PMC7267122 DOI: 10.1002/rmv.2113] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2020] [Revised: 04/17/2020] [Accepted: 04/20/2020] [Indexed: 12/18/2022]
Abstract
The pandemic of 2019 novel coronavirus (SARS‐CoV‐2019), reminiscent of the 2002‐SARS‐CoV outbreak, has completely isolated countries, disrupted health systems and partially paralyzed international trade and travel. In order to be better equipped to anticipate transmission of this virus to new regions, it is imperative to track the progress of the virus over time. This review analyses information on progression of the pandemic in the past 3 months and systematically discusses the characteristics of SARS‐CoV‐2019 virus including its epidemiologic, pathophysiologic, and clinical manifestations. Furthermore, the review also encompasses some recently proposed conceptual models that estimate the spread of this disease based on the basic reproductive number for better prevention and control procedures. Finally, we shed light on how the virus has endangered the global economy, impacting it both from the supply and demand side.
Collapse
Affiliation(s)
- Danish Rafiq
- Department of Electrical Engineering, National Institute of Technology, Srinagar, India
| | - Asiya Batool
- CSIR-Indian Institute of Integrative Medicine (IIIM), Srinagar, India
| | - M A Bazaz
- Department of Electrical Engineering, National Institute of Technology, Srinagar, India
| |
Collapse
|
27
|
Narang K, Ibirogba ER, Elrefaei A, Trad ATA, Theiler R, Nomura R, Picone O, Kilby M, Escuriet R, Suy A, Carreras E, Tonni G, Ruano R. SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines. J Clin Med 2020; 9:E1521. [PMID: 32443538 PMCID: PMC7291307 DOI: 10.3390/jcm9051521] [Citation(s) in RCA: 41] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2020] [Revised: 05/11/2020] [Accepted: 05/14/2020] [Indexed: 11/16/2022] Open
Abstract
Since the declaration of the global pandemic of COVID-19 by the World Health Organization on 11 March 2020, we have continued to see a steady rise in the number of patients infected by SARS-CoV-2. However, there is still very limited data on the course and outcomes of this serious infection in a vulnerable population of pregnant patients and their fetuses. International perinatal societies and institutions including SMFM, ACOG, RCOG, ISUOG, CDC, CNGOF, ISS/SIEOG, and CatSalut have released guidelines for the care of these patients. We aim to summarize these current guidelines in a comprehensive review for patients, healthcare workers, and healthcare institutions. We included 15 papers from 10 societies through a literature search of direct review of society's websites and their journal publications up till 20 April 2020. Recommendations specific to antepartum, intrapartum, and postpartum were abstracted from the publications and summarized into Tables. The summary of guidelines for the management of COVID-19 in pregnancy across different perinatal societies is fairly consistent, with some variation in the strength of recommendations. It is important to recognize that these guidelines are frequently updated, as we continue to learn more about the course and impact of COVID-19 in pregnancy.
Collapse
Affiliation(s)
- Kavita Narang
- Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA; (K.N.); (E.R.I.); (A.E.); (A.T.A.T.)
| | - Eniola R. Ibirogba
- Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA; (K.N.); (E.R.I.); (A.E.); (A.T.A.T.)
| | - Amro Elrefaei
- Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA; (K.N.); (E.R.I.); (A.E.); (A.T.A.T.)
| | - Ayssa Teles Abrao Trad
- Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA; (K.N.); (E.R.I.); (A.E.); (A.T.A.T.)
| | - Regan Theiler
- Obstetrics Division, Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA;
| | - Roseli Nomura
- Department of Obstetrics and Gynecology, Escola Paulista de Medicina—Universidade Federal de São Paulo, São Paulo 04021, Brazil;
| | - Olivier Picone
- Groupe de Recherche sur les Infections pendant la Grossesse (GRIG), CNGOF, Service de Gynécologie-Obstétrique Colombes, Publique-Hôpitaux de Paris, Hôpital Louis Mourier, Université de Paris, Inserm IAME-U1137, 75000 Paris, France;
| | - Mark Kilby
- Fetal Medicine Centre, Birmingham Women’s and Children’s Foundation Trust, College of Medical & Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK;
| | - Ramón Escuriet
- Catalan Health Service, Government of Catalonia, 080028 Barcelona, Spain;
| | - Anna Suy
- Department of Obstetrics and Gynecology, Hospital Universitari Vall d’Hebron, 080028 Barcelona, Spain; (A.S.); (E.C.)
| | - Elena Carreras
- Department of Obstetrics and Gynecology, Hospital Universitari Vall d’Hebron, 080028 Barcelona, Spain; (A.S.); (E.C.)
| | - Gabriele Tonni
- Prenatal Diagnostic Division, Department of Obstetrics and Gynecology, AUSL di Reggio Emilia Istituto di Ricerca a Carattere Clinico Scientifico, 42100 Reggio Emilia, Italy;
| | - Rodrigo Ruano
- Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA; (K.N.); (E.R.I.); (A.E.); (A.T.A.T.)
| |
Collapse
|
28
|
Affiliation(s)
- P Deruelle
- Pôle de gynécologie, obstétrique et fertilité, hôpitaux universitaires de Strasbourg, 67000 Strasbourg, France.
| | - F De Marcillac
- Pôle de gynécologie, obstétrique et fertilité, hôpitaux universitaires de Strasbourg, 67000 Strasbourg, France
| |
Collapse
|
29
|
Donders F, Lonnée-Hoffmann R, Tsiakalos A, Mendling W, Martinez de Oliveira J, Judlin P, Xue F, Donders GGG. ISIDOG Recommendations Concerning COVID-19 and Pregnancy. Diagnostics (Basel) 2020; 10:E243. [PMID: 32338645 PMCID: PMC7235990 DOI: 10.3390/diagnostics10040243] [Citation(s) in RCA: 50] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Revised: 04/16/2020] [Accepted: 04/18/2020] [Indexed: 12/15/2022] Open
Abstract
Providing guidelines to health care workers during a period of rapidly evolving viral pandemic infections is not an easy task, but it is extremely necessary in order to coordinate appropriate action so that all patients will get the best possible care given the circumstances they are in. With these International Society of Infectious Disease in Obstetrics and Gynecology (ISIDOG) guidelines we aim to provide detailed information on how to diagnose and manage pregnant women living in a pandemic of COVID-19. Pregnant women need to be considered as a high-risk population for COVID-19 infection, and if suspected or proven to be infected with the virus, they require special care in order to improve their survival rate and the well-being of their babies. Both protection of healthcare workers in such specific care situations and maximal protection of mother and child are envisioned.
Collapse
Affiliation(s)
| | | | - Aristotelis Tsiakalos
- Department Ob/Gyn, LETO Obstetrician Gynecological & Surgical Center, 11525 Athens, Greece;
| | - Werner Mendling
- German Center for Infections in Gynecology and Obstetrics, 42283 Wuppertal, Germany;
| | | | - Philippe Judlin
- Department OB/Gyn, CHU De Nancy—Université de Lorraine, 54000 Nancy, France;
| | - Fengxia Xue
- Department OB/Gyn, Tianjin Medical University General Hospital, Tianjin 30000, China;
| | - Gilbert G. G. Donders
- Femicare VZW Clinical Research for Women, 3300 Tienen, Belgium;
- Department Ob/Gyn, University Hospital Antwerp, 2650 Ekeren, Belgium
| | | |
Collapse
|
30
|
Delet J, Ablancous L, Miel A, Voluménie JL, Monthieux A. Covid-19 et soins périnataux : l’expérience de la Martinique. SAGES-FEMMES 2020; 19. [PMCID: PMC7388758 DOI: 10.1016/j.sagf.2020.07.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 12/07/2022]
Abstract
La Martinique, alors en phase 2 de l’épidémie de Covid-19, a appliqué, en mars 2020, les mesures de confinement décidées au niveau national, ce qui a rendu nécessaire une réorganisation de l’offre de soins en périnatalité. De nouvelles méthodes de travail ont émergé, fruit de la disponibilité, de l’adaptabilité et de la créativité des professionnels. Cette expérience devrait les conduire à renforcer les stratégies d’accompagnement des femmes, à mieux appréhender l’avenir et à développer la formation des soignants aux enjeux psychologiques de la gestion de crise sanitaire.
Collapse
|
31
|
Faatau-Itchener S. Prévention de la propagation de la Covid-19 en Polynésie française. SAGES-FEMMES 2020. [PMCID: PMC7392068 DOI: 10.1016/j.sagf.2020.07.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 12/07/2022]
Abstract
La Polynésie française est une collectivité d’outre-mer de la République française regroupant 118 îles. Située en plein océan Pacifique, elle a dû relever un défi majeur pour freiner l’entrée du virus Sars-CoV-2, tout en assurant la continuité des soins auprès de sa population répartie sur ses cinq archipels. Le risque d’infection à Covid-19 chez la femme enceinte a constitué une forte préoccupation, notamment en raison du taux élevé d’obésité sur le territoire.
Collapse
|